Sphere Fluidics' Series A Round

Sphere Fluidics raised a round of funding on February 10, 2016.

Spher Fluidics provides Cyto-Mine technology, an integrated device that uses picodroplet technology and microfluidics to process around 1 million heterogeneous mammalian cells in less than half a day.…

Articles about Sphere Fluidics' Series A Round: